Connecticut-based Z-Medical announced this month that it acquired the Novacol resorbable hemostatic product line from rival TAUREON, headquartered in The Netherlands.
TAUREON said that it hopes to focus more on its core businesses, giving over the Novacol line to Z-Medica and its vast distribution network. The companies did not disclose the terms of the deal.
"Z-Medica’s experience with QuikClot and their reputation as a leader in the hemostatic market ensures that Novacol will be able to compete favorably in the market," TAUREON CEO Dick van Kalkeren said in prepared remarks. "The transfer of Novacol also enables TAUREON to strengthen our focus in Europe on plastic and orthopedic surgery, human tissue and advanced wound care."
Z-Medica president & CEO Stephen Fanning called the acquisition a "natural fit" for the company and its existing portfolio of hemostatic products, used to stop bleeding "wherever it occurs." Novacol is a collagen fiber product used primarily during surgeries to stop bleeding in cavities and irregular surfaces.